ABOUT OUR COMPANY
SAIL Fusion is an early-stage medical device company that has developed an novel, patented treatment for sacroiliac joint dysfunction. The device fuses the sacroiliac joint to address a common, and increasingly diagnosed cause of lower back pain. This system uses a novel, posterior mini-open approach for maximum joint preparation and graft delivery. The technique is built on the principles of the AO Foundation, which are the basis for all established orthopedic surgical techniques.
The SAIL Fusion system was inspired by a group of leading orthopedic and neuro surgeons. These ideas were incubated by a team of spinal industry veterans, who have developed some of the leading orthopedic products available today. Pending regulatory review and clearance, the SAIL Fusion system plans to build the future of sacroiliac treatment.
SI FUSION MARKET
With increasing clinical evidence identifying SI joint dysfunction as the cause of up to 30% of lower back pain, the SI joint fusion has seen outstanding year-over-year growth within the orthopedic medical device market with a CAGR of 19%. The global SI joint fusion market is estimated to reach USD 530M by 2027 thanks to both the rapidly increasing number of procedures, as well as the established reimbursement codes for minimally invasive and open SI joint fusion surgeries.¹²
SAIL FUSION TEAM
Director, Product Strategy
Director, Market Development
Business Development Manager